SCHEMBL29697303

SCHEMBL29697303

CNc1ccc2cccnc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
EGFR P00533 1/20 0.56
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
CASP1 P29466 1/20 0.53
CASP7 P55210 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2C19 P33261 1/20 0.53
HTT P42858 1/20 0.53
NR4A2 P43354 1/20 0.53
P2RY14 Q15391 2/20 0.48
NOTUM Q6P988 1/20 0.47
TRPV1 Q8NER1 2/20 0.46
PDGFRB P09619 1/20 0.46
PDGFRA P16234 1/20 0.46
DDB1 Q16531 1/20 0.46
CRBN Q96SW2 1/20 0.46
BAZ1A Q9NRL2 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
CYP3A4 P08684 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3072828 1.00 ALDH1A1 (0.58) ALDH1A1EGFRMEN1KMT2ACASP1
SCHEMBL2162877 0.86 ALDH1A1 (0.51) ALDH1A1EGFRMEN1KMT2ACASP1
SCHEMBL3155590 0.85 NPC1 (0.62) ALDH1A1EGFRMEN1KMT2ACASP1
SCHEMBL22658423 0.81 ALDH1A1 (0.53) ALDH1A1MEN1KMT2ACASP1CASP7
SCHEMBL598102 0.81 NR4A2 (0.58) ALDH1A1MEN1KMT2ACASP1CASP7
SCHEMBL14805621 0.80 ALDH1A1 (0.53) ALDH1A1MEN1KMT2ACASP1CASP7
SCHEMBL20206686 0.80 ALDH1A1 (0.53) ALDH1A1MEN1KMT2ACASP1CASP7
SCHEMBL12890525 0.80 ALDH1A1 (0.53) ALDH1A1MEN1KMT2ACASP1CASP7
Hydrochloric Acid SCHEMBL25219076 0.79 ALDH1A1 (0.52) ALDH1A1MEN1KMT2ACASP1CASP7
SCHEMBL21101485 0.78 ALDH1A1 (0.58) ALDH1A1MEN1KMT2ACASP1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4010080-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER Artios Pharma Limited (GB) 2022-06-15 EP disclosed